S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:CLDX

Celldex Therapeutics News Headlines

$25.20
-1.32 (-4.98 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.18
Now: $25.20
$26.64
50-Day Range
$17.53
MA: $22.94
$29.91
52-Week Range
$1.50
Now: $25.20
$30.17
Volume640,162 shs
Average Volume619,309 shs
Market Capitalization$997.09 million
P/E RatioN/A
Dividend YieldN/A
Beta2.96

Headlines

Celldex Therapeutics (NASDAQ CLDX) News Headlines Today

Source:
SourceHeadline
Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $35.00 at Cantor FitzgeraldCelldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $35.00 at Cantor Fitzgerald
marketbeat.com - February 23 at 7:45 AM
Celldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week High Following Analyst UpgradeCelldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week High Following Analyst Upgrade
americanbankingnews.com - March 2 at 11:28 AM
Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $36.00 at HC WainwrightCelldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $36.00 at HC Wainwright
americanbankingnews.com - March 1 at 11:29 AM
HC Wainwright Increases Celldex Therapeutics (NASDAQ:CLDX) Price Target to $36.00HC Wainwright Increases Celldex Therapeutics (NASDAQ:CLDX) Price Target to $36.00
americanbankingnews.com - February 23 at 9:44 AM
Cantor Fitzgerald Increases Celldex Therapeutics (NASDAQ:CLDX) Price Target to $35.00Cantor Fitzgerald Increases Celldex Therapeutics (NASDAQ:CLDX) Price Target to $35.00
americanbankingnews.com - February 23 at 9:44 AM
Celldex Therapeutics To Test CDX-0159 In Chronic Itchy Skin DisorderCelldex Therapeutics To Test CDX-0159 In Chronic Itchy Skin Disorder
feeds.benzinga.com - February 23 at 6:35 AM
Celldex Therapeutics to Expand Development of CDX-0159 into Prurigo Nodularis (PN)Celldex Therapeutics to Expand Development of CDX-0159 into Prurigo Nodularis (PN)
finance.yahoo.com - February 22 at 7:13 PM
Celldex Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare ConferenceCelldex Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 22 at 9:11 AM
Celldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week High at $26.00Celldex Therapeutics (NASDAQ:CLDX) Reaches New 52-Week High at $26.00
americanbankingnews.com - February 17 at 12:23 PM
Celldex Therapeutics (NASDAQ:CLDX) Share Price Crosses Above 200 Day Moving Average of $16.42Celldex Therapeutics (NASDAQ:CLDX) Share Price Crosses Above 200 Day Moving Average of $16.42
americanbankingnews.com - February 17 at 2:21 AM
Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 7.1%Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 7.1%
americanbankingnews.com - February 9 at 9:06 PM
Announcing: Celldex Therapeutics (NASDAQ:CLDX) Stock Soared An Exciting 736% In The Last YearAnnouncing: Celldex Therapeutics (NASDAQ:CLDX) Stock Soared An Exciting 736% In The Last Year
finance.yahoo.com - January 26 at 8:31 AM
Do Options Traders Know Something About Celldex (CLDX) Stock We Dont?Do Options Traders Know Something About Celldex (CLDX) Stock We Don't?
finance.yahoo.com - January 8 at 1:24 PM
Celldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General CounselCelldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General Counsel
finance.yahoo.com - January 4 at 9:31 AM
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020These 5 Small-Cap Healthcare Stocks Gained the Most in 2020
finance.yahoo.com - December 23 at 7:21 AM
Celldex Doses First Patient in Phase 1b Study of CDX-0159 in Chronic Inducible UrticariaCelldex Doses First Patient in Phase 1b Study of CDX-0159 in Chronic Inducible Urticaria
finance.yahoo.com - December 9 at 9:08 AM
Celldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx ConferenceCelldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 30 at 5:15 PM
Heres Why Were Not Too Worried About Celldex Therapeutics (NASDAQ:CLDX) Cash Burn SituationHere's Why We're Not Too Worried About Celldex Therapeutics' (NASDAQ:CLDX) Cash Burn Situation
finance.yahoo.com - November 27 at 9:19 AM
Celldex Presents Data from Oncology Portfolio at SITC 2020Celldex Presents Data from Oncology Portfolio at SITC 2020
finance.yahoo.com - November 9 at 12:52 PM
Celldex Provides Corporate Update and Reports Third Quarter 2020 ResultsCelldex Provides Corporate Update and Reports Third Quarter 2020 Results
finance.yahoo.com - November 5 at 7:57 PM
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue EstimatesCelldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 5 at 7:57 PM
2 Biotech Stocks That Keep on Climbing2 Biotech Stocks That Keep on Climbing
finance.yahoo.com - October 23 at 9:36 AM
Celldex Initiates Early-Stage Antibody Study for Skin DisorderCelldex Initiates Early-Stage Antibody Study for Skin Disorder
nasdaq.com - October 14 at 12:50 PM
Dosing underway in Celldex Therapeutics CDX-0159 early-stage skin disorder studyDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder study
seekingalpha.com - October 13 at 4:47 PM
Celldex Therapeutics Says First Patient Dosed In Phase 1b Study Of CDX-0159 - Quick FactsCelldex Therapeutics Says First Patient Dosed In Phase 1b Study Of CDX-0159 - Quick Facts
nasdaq.com - October 13 at 4:47 PM
Why Celldex Has Been A Big Winner In 2020Why Celldex Has Been A Big Winner In 2020
seekingalpha.com - October 1 at 4:46 AM
Celldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise ofCelldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise of
bloomberg.com - September 30 at 5:33 PM
Is the Options Market Predicting a Spike in Celldex Therapeutics (CLDX) Stock?Is the Options Market Predicting a Spike in Celldex Therapeutics (CLDX) Stock?
nasdaq.com - September 29 at 12:48 PM
Stock Alert: Celldex Therapeutics Climbs To New 52-week HighStock Alert: Celldex Therapeutics Climbs To New 52-week High
nasdaq.com - September 28 at 2:41 PM
Celldex Therapeutics to Present at Upcoming Healthcare ConferencesCelldex Therapeutics to Present at Upcoming Healthcare Conferences
finance.yahoo.com - September 10 at 6:50 PM
Celldex launches early-stage study for bispecific candidate in solid tumorsCelldex launches early-stage study for bispecific candidate in solid tumors
seekingalpha.com - August 24 at 5:26 PM
Celldex Therapeutics Initiates Phase 1 Study of New Bispecific Product Candidate CDX-527 in Solid TumorsCelldex Therapeutics Initiates Phase 1 Study of New Bispecific Product Candidate CDX-527 in Solid Tumors
finance.yahoo.com - August 24 at 12:25 PM
Celldex Therapeutics (CLDX) CEO Anthony Marucci on Q2 2020 Results - Earnings Call TranscriptCelldex Therapeutics' (CLDX) CEO Anthony Marucci on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 10:53 PM
Celldex Provides Corporate Update and Reports Second Quarter 2020 ResultsCelldex Provides Corporate Update and Reports Second Quarter 2020 Results
finance.yahoo.com - August 6 at 5:53 PM
Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update CallCelldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call
finance.yahoo.com - August 3 at 12:47 PM
Celldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseCelldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 29 at 2:00 PM
Will the Celldex Therapeutics Inc (NAQ:CLDX) share price keep rising?Will the Celldex Therapeutics Inc (NAQ:CLDX) share price keep rising?
uk.finance.yahoo.com - July 8 at 3:18 PM
Celldex Therapeutics, Inc. (CLDX) Shares March Higher, Can It Continue?Celldex Therapeutics, Inc. (CLDX) Shares March Higher, Can It Continue?
finance.yahoo.com - July 8 at 10:15 AM
Heres Why Celldex Therapeutics Stock Is Soaring TodayHere's Why Celldex Therapeutics Stock Is Soaring Today
www.fool.com - June 19 at 5:08 PM
RTW Investments acquires 9.95% stakes in Celldex TherapeuticsRTW Investments acquires 9.95% stakes in Celldex Therapeutics
seekingalpha.com - June 19 at 11:37 AM
Celldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional SharesCelldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 18 at 2:43 PM
Celldex Therapeutics slips 8% after pricing equity offeringCelldex Therapeutics slips 8% after pricing equity offering
seekingalpha.com - June 16 at 7:05 AM
Celldex Therapeutics Announces Pricing of $130.4 Million Public Offering of Common StockCelldex Therapeutics Announces Pricing of $130.4 Million Public Offering of Common Stock
finance.yahoo.com - June 15 at 10:38 PM
Celldex Jumps On CDX-0159 DataCelldex Jumps On CDX-0159 Data
seekingalpha.com - June 15 at 5:38 PM
Celldex Therapeutics Announces Proposed Public Offering of Common StockCelldex Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 15 at 5:38 PM
After a strong run, whats next for investors in Celldex Therapeutics Inc?After a strong run, what's next for investors in Celldex Therapeutics Inc?
uk.finance.yahoo.com - June 15 at 7:33 AM
Insider Buys Celldex Therapeuticss StockInsider Buys Celldex Therapeutics's Stock
finance.yahoo.com - June 12 at 2:53 PM
Thinking about buying stock in Celldex Therapeutics, eMagin Corp, TOP Ships, Party City, or Alaska Air?Thinking about buying stock in Celldex Therapeutics, eMagin Corp, TOP Ships, Party City, or Alaska Air?
www.benzinga.com - June 12 at 9:52 AM
Stocks Trading Above 20 Days Moving Average: $CLDX $JRJC $BTEStocks Trading Above 20 Days Moving Average: $CLDX $JRJC $BTE
www.marketwatch.com - June 11 at 1:10 PM
Insider Buys Celldex Therapeutics SharesInsider Buys Celldex Therapeutics' Shares
www.benzinga.com - June 11 at 1:10 PM
Implied Volatility Surging for Celldex Therapeutics (CLDX) Stock OptionsImplied Volatility Surging for Celldex Therapeutics (CLDX) Stock Options
finance.yahoo.com - June 11 at 1:10 PM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.